Blue Jet Healthcare last traded at ₹519.20 (2026-10-13). Over the past month the stock moved -9.7%, three months the stock moved +3.9%, year the stock moved -21.7%. Its closing range over 52 weeks is ₹343.80 – ₹656.40, with the latest close 20.9% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1968, Blue Jet Healthcare (earlier called Jet Chemicals Pvt Ltd) is a pharmaceutical and healthcare ingredient & intermediate company and the first manufacturer of saccharin and its salts (artificial sweeteners) in India.[1]
Product Portfolio A) Contrast Media Intermediates (67.7% of FY24 revenue)[1] Contrast media are chemical agents that enhance imaging clarity for diagnostic purposes, making tissues more visible under X-rays, CT scans, MRIs, and ultrasounds. The company supplies critical starting and advanced intermediates to the world's top contrast media manufacturers.
In the latest quarter (Jun 2026), Blue Jet Healthcare reported sales of ₹293.00 crore (-17.5%) and net profit of ₹78.00 crore (-14.3%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 293.00 | 98.00 | 33.00 | 78.00 | 4.51 |
| Mar 2026 | 235.00 | 71.00 | 30.00 | 64.00 | 3.71 |
| Dec 2025 | 192.00 | 47.00 | 24.00 | 40.00 | 2.32 |
| Sep 2025 | 165.00 | 55.00 | 33.00 | 52.00 | 3.01 |
| Jun 2025 | 355.00 | 121.00 | 34.00 | 91.00 | 5.26 |
| Mar 2025 | 340.00 | 140.00 | 41.00 | 110.00 | 6.35 |
| Dec 2024 | 318.00 | 124.00 | 39.00 | 99.00 | 5.71 |
| Sep 2024 | 208.00 | 69.00 | 33.00 | 58.00 | 3.36 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +14.9% | +90.4% | +84.8% | +117.8% | -20.7% | -39.6% | -30.9% | -17.5% |
| Operating profit growth | +9.5% | +125.5% | +164.2% | +175.0% | -20.3% | -62.1% | -49.3% | -19.0% |
| Net profit growth | +20.8% | +209.4% | +175.0% | +139.5% | -10.3% | -59.6% | -41.8% | -14.3% |
| EPS growth | +21.7% | +208.6% | +177.3% | +141.3% | -10.4% | -59.4% | -41.6% | -14.3% |
| OPM % | 33.0% | 39.0% | 41.0% | 34.0% | 33.0% | 24.0% | 30.0% | 33.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Blue Jet Healthcare reported sales of ₹947.00 crore (-8.1%) and net profit of ₹248.00 crore (-18.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 947.00 | 294.00 | 31.00 | 248.00 | 14.29 |
| Mar 2025 | 1,030 | 378.00 | 37.00 | 305.00 | 17.59 |
| Mar 2024 | 712.00 | 231.00 | 32.00 | 164.00 | 9.44 |
| Mar 2023 | 721.00 | 219.00 | 30.00 | 160.00 | 9.23 |
| Mar 2022 | 683.00 | 249.00 | 36.00 | 182.00 | 10.47 |
| Mar 2021 | 499.00 | 207.00 | 41.00 | 142.00 | 1,428.57 |
| Mar 2020 | 538.00 | 214.00 | 40.00 | 145.00 | 24,118.33 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales growth | -7.2% | +36.9% | +5.6% | -1.2% | +44.7% | -8.1% |
| Operating profit growth | -3.3% | +20.3% | -12.0% | +5.5% | +63.6% | -22.2% |
| Net profit growth | -2.1% | +28.2% | -12.1% | +2.5% | +86.0% | -18.7% |
| EPS growth | -94.1% | -99.3% | -11.8% | +2.3% | +86.3% | -18.8% |
| OPM % | 41.0% | 36.0% | 30.0% | 32.0% | 37.0% | 31.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Blue Jet Healthcare.
Get Free AI Stock Analysis FREE →Blue Jet Healthcare Plans ₹1,000 Crore Vizag Plant Expansion - whalesbook.com
Blue Jet Healthcare standalone net profit declines 14.16% in the June 2026 quarter - Business Standard
Trade Spotlight: How should you trade Alkem Labs, Blue Jet Healthcare, CreditAccess Grameen, Minda... - Moneycontrol.com
Blue Jet Healthcare Q1 Results: Earnings Call Set for August 3 - scanx.trade
Blue Jet Healthcare promoter declares no encumbrance on 79.81% stake - scanx.trade
Blue Jet Healthcare wins EcoVadis Silver Medal for sustainability - scanx.trade
Blue Jet Healthcare shares rise after the launch of QIP at the floor price of ₹531.70 per share
Blue Jet Healthcare gains after launching QIP; floor price set at Rs 531.70/share - Business Standard
Stock Crash: Blue Jet Healthcare shares tank 10% after revenue, profit fall in Q2
Blue Jet Healthcare down 4% as promoter launches OFS at ₹675; check details
Blue Jet Healthcare shares were last quoted at ₹519.20 (+0.9% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Blue Jet Healthcare has a price-to-earnings (P/E) ratio of 42.13 and a price-to-book (P/B) ratio of 27.14. The industry P/E is 53.33.
The 52-week high of Blue Jet Healthcare is ₹693.15 and the 52-week low is ₹325.20.
The market capitalisation of Blue Jet Healthcare is about ₹9,896.20 crore.
In the latest quarter (Jun 2026), Blue Jet Healthcare reported sales of ₹293.00 crore (-17.5%) and net profit of ₹78.00 crore (-14.3%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Blue Jet Healthcare has a 3-year ROE of 24.00%, 3-year profit growth of 16.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 73.15% of Blue Jet Healthcare.
Blue Jet Healthcare belongs to the Pharmaceuticals & Drugs sector.